Carolyn Borders
Chief Investor Relations Officer
Replay available
GE HealthCare Technologies Inc. (NASDAQ: GEHC) Q2 2026 earnings conference call, held 2026-07-29. Replay captured from the company's public earnings webcast.

Chief Investor Relations Officer
President and CEO
Vice President and CFO
Analyst, Wells Fargo
Analyst, Evercore ISI
Analyst, Stifel
Analyst, BMO
Analyst, Bank of America Securities
Analyst, Jefferies
Good day and thank you for standing by. Welcome to the GE HealthCare second quarter 2026 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during this session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Carolyn Borders, Chief Investor Relations Officer. Ma'am, please go ahead. Thanks, Operator. Good morning and welcome to GE Healthcare's second quarter 2026 earnings call. I'm joined by our President and CEO, Peter Arduini, Vice President and CFO, Jay Saccaro, and our Controller and Chief Accounting Officer, George Newcomb. Our conference call remarks will include both GAAP and non-GAAP financial results. Reconciliations between GAAP and non-GAAP measures can be found in today's press release and in the presentation slides available on our website. During this call, we'll make forward-looking statements about our performance. These statements are based on how we see things today. As described in our SEC filings, actual results may differ materially due to risks and uncertainties. And with that, I'll hand the call over to Peter. Thanks, Carolyn. Good morning, and thank you for joining us today. We were pleased with our strong performance in the second quarter. Quarters increased 11% with strong backlog, which grew $2.6 billion year over year, and booked a bill of 1.15 times, all of which were at record levels. We're seeing healthy end market demand in all three of our segments and acr...